Q3 2025 Astrana Health Inc Earnings Call Transcript

Nov 6, 2025 / 10:30 PM GMT

Release Date Price: $33.36 (+0.36%)

Transcript 10-Q8-K

Key Points

Positve

Astrana Health Inc (ASTH) reported a strong financial performance in Q3 2025, with total revenues reaching $956 million, marking a 100% year-over-year increase.
The integration of Prospect Health has been successful, contributing significantly to the company's revenue growth and expanding its scale and capabilities.
The company achieved an adjusted EBITDA of $68.5 million, up 52% year-over-year, demonstrating strong profitability even as it scales aggressively.
Astrana Health Inc (ASTH) has expanded its strategic partnerships, including a collaboration with Intermountain Health in Nevada, enhancing its market presence.
The company is leveraging AI technology to improve efficiency and care quality, with predictive models and AI-driven tools being deployed across various operations.

Negative

The transition of several payer contracts from partial risk to full risk arrangements has been delayed to Q1 2026, impacting the 2025 revenue guidance.
There are anticipated headwinds in the Medicaid and exchange businesses due to evolving regulatory dynamics, which may pressure membership and rates.
The integration of Prospect Health, while successful, has resulted in a slightly higher medical cost trend compared to the legacy Astrana business.
The company faces challenges in managing Medicaid cost trends, which continue to be above expectations despite improvements from Q2.
There is some exposure to the exchanges, which, although small, could present risks given the current regulatory environment.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ASTH.OQ - Astrana Health Inc
Q3 2025 Astrana Health Inc Earnings Call
Nov 06, 2025 / 10:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day everyone, and welcome to Astronna's Health 3rd quarter 2025 earnings call. At this time, all participants are in a listen-only mode. Later, you have the opportunity to ask questions during the question-and-answer session, and instructions will be provided at that time.

Today's speakers will be Brandon Sim, President and Chief Executive Officer of Estrada Health, and Chan Basso, Chief Operating and Financial Officer.

This press release announcing astronna's Health results for the third quarter ended September 30th, 2025 is available at the investor section of the company's website at wwastronnahealth.com.

The company will discuss certain non-GAAP measures during this call. Reconciliation to the most

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.